Month: June 2021

The city of dreams, Mumbai is everything you have ever dreamt of. It offers an opportunity to change your life and to live the life of your dreams. Whether you are new to the city or have been living here for many years, there is no joy like exploring the city on your two wheeler. Owning a two wheeler brings pride and thrill but if you are still wondering whether you want to buy one or not, now is the time to turn the dreams into a reality. You can own any two wheeler of your choice with two wheeler loans in Mumbai. Hero FinCorp offers the loan for every brand and type of two wheeler in the country. Simply scout the market for two wheelers and shortlist the ones that you are keen on buying. Whether this is your first two wheeler or you already own one, you must remember to take a test drive on it. Do not purchase the two wheeler without...

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancerSanofi partnering with the Breast International Group (BIG), the European Organization for Research and Treatment of Cancer (EORTC) and Alliance Foundation Trials (AFT), which are world-leading academic groups delivering practice-changing breast cancer clinical research Collaborating on the Phase 3 AMEERA-6 study expected to be the first pivotal trial of an oral selective estrogen receptor degrader (SERD) in the adjuvant setting and will evaluate the safety and efficacy of Sanofi’s investigational amcenestrant in estrogen receptor-positive (ER+) patients who prematurely discontinue standard therapy and have high risk of disease recurrence Parties to finalize full terms of...

Burlingame, California, June 03, 2021 (GLOBE NEWSWIRE) — Carney Technology Acquisition Corp. II (NASDAQ: CTAQ) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) as a result of its inability to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) in a timely fashion. The Notice advised the Company that it was not in compliance with Nasdaq’s continued listing requirements under the timely filing criteria established in Nasdaq Listing Rule 5250(c)(1) (the “Rule”). As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on May 17, 2021, the Company was unable to file its Form 10-Q within the prescribed time period...

MONTRÉAL, June 03, 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Corporation”) today announced that it has successfully priced its previously announced offering of US$1,000,000,000 aggregate principal amount, which has been upsized to US$1,200,000,000 aggregate principal amount, of new Senior Notes due 2026. The new Senior Notes will carry a coupon of 7.125% per annum and will be sold at 100.000% of par (the “New Notes”). The issuance is expected to close on or about June 8, 2021, subject to customary closing conditions. The net proceeds of the offering are expected to be used to finance Bombardier’s tender offer (the “Tender Offer”), for up to $1,000,000,000 in aggregate purchase price, of its outstanding (i) 5.750% Senior Notes due 2022 (the “5.750% 2022 Notes”), of which there is US$181,203,000 principal amount...

The board of directors of IDEX Biometrics ASA has resolved to issue 972,642 ordinary shares at NOK 2.08 per share to employees who participate in the company’s Employee Share Purchase Plan (ESPP), which plan was approved by the annual general meeting on 15 May 2020. 54 employees participated in the ESPP in this period. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every three months. The shares are restricted for three months. Following the issue, the Company’s share capital will be NOK 137,734,306.50 divided into 918,228,710 shares each with a nominal value of NOK 0.15. Primary insidersIDEX discloses transactions by the following primary insiders in IDEX shares ISIN NO0003070609:–   CEO Vince Graziani acquired 19,984 ordinary shares at...

The board of directors of IDEX Biometrics ASA resolved on 3 June 2021 to issue 2,000,000 incentive subscription rights to an officer in the IDEX group. The grant was made under the company’s 2021 incentive subscription rights plan as resolved at the annual general meeting on 12 May 2021. The exercise price of the subscription rights is NOK 2.38 per share. The subscription rights vest by 25% per year over four years and expire on 12 May 2026. Following the grant there are 62,053,609 subscription rights outstanding in IDEX. Primary insiderCatharina Eklof, Chief Commercial Officer of IDEX Biometrics ASA, received on 3 June 2021 a grant of 2,000,000 incentive subscription rights to shares in IDEX. The grant was made for no consideration. IDEX shares have ISIN NO0003070609. For further information contact:Marianne Bøe, Investor Relations...

TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Celestica Inc. (NYSE: CLS)(TSX: CLS), a leader in design, manufacturing and supply chain solutions for the world’s most innovative companies, hosted an analyst and investor virtual roundtable on its Capital Equipment business and provided a confirmatory business update, today after market close. During the virtual meeting, Celestica’s management provided participants with an in-depth overview of its Capital Equipment business, reaffirmed its Q2 2021 guidance in the context of recent developments in the market (further to its press release of May 26, 2021 announcing the virtual roundtable), and conducted a Q&A with analysts. Speakers were CEO Rob Mionis, CFO Mandeep Chawla and Vice President, Capital Equipment, Gregory Marvell. Below is a summary of the highlights of the discussion...

San Marcos, TX, June 03, 2021 (GLOBE NEWSWIRE) — Quantum Materials Corp (QTMM) (“Quantum” or the “Company”), a leading American nanomaterial and cadmium free quantum dot producer and product company, is issuing this release to provide shareholder and investors with information regarding the Company and in light of the 10 trading day order of suspension issued by the Securities and Exchange Commission (the “Commission”) on May 12, 2021 due to a lack of current information as a result of the failure to file certain periodic reports under the Company’s reporting obligations with the Commission. The trading halt, which commenced at 9:30am on May 13, 2021 and terminated at 11:59pm on May 26, 2021, has resulted in the Company’s shares no longer being quoted or traded on the Pink Tier operated by the OTC Markets Group, Inc. At this time,...